精鍛科技(300258.SZ):擬5000萬元投資參股武漢格藍若智能機器人
格隆匯6月3日丨精鍛科技(300258.SZ)公佈,2025年5月30日,江蘇太平洋精鍛科技股份有限公司第五屆董事會第十一次會議審議通過了《關於對外投資的議案》,同意公司對外投資參股武漢格藍若智能機器人有限公司(以下簡稱“標的公司”),並於2025年6月1日與交易各方簽署了相關增資認股協議和股東協議。
公司爲了佈局人形機器人核心供應鏈,搶佔未來產業制高點,實現技術協同與業務升級,擬以自有資金人民幣5000萬元,參與標的公司A輪融資,持有標的公司10%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.